[Assessment of an intervention on cardiovascular risk factors in patients with rheumatoid arthritis]

Andrea Zacarías1, Javier Narváez1, Jesús Rodríguez Moreno1

  • 1Servicio de Reumatología, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España.

Medicina Clinica
|May 5, 2016
PubMed

Insights

An intervention identified new cardiovascular risk factors (CVRF) in nearly half of rheumatoid arthritis patients, but overall CVRF control remained low. This highlights a need for improved CVRF management strategies in this population.

Area of Science:

  • Rheumatology
  • Cardiology
  • Public Health

Background:

  • Rheumatoid arthritis (RA) patients face increased cardiovascular risk.
  • Effective management of cardiovascular risk factors (CVRF) is crucial for RA patients.
  • Current interventions may not sufficiently improve CVRF control in RA.

Purpose of the Study:

  • To assess the efficacy of an intervention aimed at improving CVRF control in patients with rheumatoid arthritis.
  • To identify undiagnosed CVRF in RA patients.
  • To evaluate the impact of physician-directed CVRF management on RA patients.

Main Methods:

  • A cohort of 211 RA patients had their CVRF and cardiovascular risk (CVR) assessed using modified SCORE.
  • Patients received a letter for their general practitioner detailing CVRF and LDL cholesterol goals.
  • Interventions and outcomes were recorded after three months.

Main Results:

  • Nearly half (47%) of patients were newly diagnosed with CVRF.
  • Significant improvements in high blood pressure (HBP) control were observed (25% to 73%).
  • Control rates for elevated LDL cholesterol (10% to 17%) and hypertriglyceridemia (25% to 38%) remained low.

Conclusions:

  • The intervention successfully identified new CVRF in a substantial proportion of RA patients.
  • The overall effectiveness of the intervention in improving CVRF control was limited.
  • Enhanced strategies are needed for comprehensive cardiovascular risk management in rheumatoid arthritis.
Abstract

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
480
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
437
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
571
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
797
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
958
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
559